Sushil Patel
Chief Commercial Officer, Replimune Group, Inc.
Companies
- Replimune Group, Inc.Board member Apr 3, 2024 to now1
- Replimune Group, Inc.Chief executive officer Apr 3, 2024 to now1
- Revolution Medicines (United States)Board member Jun 17, 2022 to now2
- Replimune Group, Inc.Chief Commercial Officer May 5, 2021 to Jun 15, 20233
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Replimune Group, Inc. REPL708,151 shares4$8.4M at $11.82Aug 10, 2026
- Revolution Medicines (United States) RVMD21,656 shares5$4.1M at $190.54Jun 29, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 10, 2026Sold 39,341 shares at $12.97 of Replimune Group, Inc.4
- Jun 29, 2026Sold 881 shares at $192.61 of Revolution Medicines (United States)5
- Jun 29, 2026Sold 541 shares at $191.87 of Revolution Medicines (United States)5
- Jun 29, 2026Sold 600 shares at $190.55 of Revolution Medicines (United States)5
- Jun 29, 2026Sold 100 shares at $188.57 of Revolution Medicines (United States)5
- Jun 29, 2026Sold 300 shares at $187.83 of Revolution Medicines (United States)5
- Jun 29, 2026Sold 858 shares at $186.92 of Revolution Medicines (United States)5
- Jun 29, 2026Sold 1,100 shares at $185.90 of Revolution Medicines (United States)5
- Jun 29, 2026Sold 900 shares at $184.59 of Revolution Medicines (United States)5
- Jun 29, 2026Sold 300 shares at $183.17 of Revolution Medicines (United States)5
- Jun 29, 2026Exercised options 2,955 shares at $37.54 of Revolution Medicines (United States)5
- Jun 18, 2026Granted 1,191 shares of Revolution Medicines (United States)6
- May 18, 2026Sold 37,324 shares at $5.08 of Replimune Group, Inc.7
- Apr 1, 2026Granted 251,240 shares of Replimune Group, Inc.8
- Dec 19, 2025Granted 200,000 shares of Replimune Group, Inc.9
- Dec 2, 2025Sold 10,000 shares at $11.13 of Replimune Group, Inc.10
- Jun 26, 2025Granted 3,142 shares of Revolution Medicines (United States)11
- May 20, 2025Sold 25,105 shares at $8.06 of Replimune Group, Inc.12
- Apr 1, 2025Granted 166,667 shares of Replimune Group, Inc.13
- Dec 16, 2024Sold 10,000 shares at $12.42 of Replimune Group, Inc.14
- Oct 31, 2024Sold 5,000 shares at $54.14 of Revolution Medicines (United States)15
- Oct 31, 2024Exercised options 5,000 shares at $24.84 of Revolution Medicines (United States)15
- Jul 9, 2024Sold 2,155 shares at $44.00 of Revolution Medicines (United States)16
- Jul 9, 2024Exercised options 2,155 shares at $16.80 of Revolution Medicines (United States)16
- Jun 20, 2024Granted 4,248 shares of Revolution Medicines (United States)17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARReplimune Group, Inc., Board member
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Jun 23, 2026
- 7SEC EDGARForm 4 filed May 20, 2026
- 8SEC EDGARForm 4 filed Apr 7, 2026
- 9SEC EDGARForm 4 filed Dec 19, 2025
- 10SEC EDGARForm 4 filed Dec 4, 2025
- 11SEC EDGARForm 4 filed Jun 30, 2025
- 12SEC EDGARForm 4 filed May 22, 2025
- 13SEC EDGARForm 4 filed Apr 3, 2025
- 14SEC EDGARForm 4 filed Dec 18, 2024
- 15SEC EDGARForm 4 filed Nov 4, 2024
- 16SEC EDGARForm 4 filed Jul 10, 2024
- 17SEC EDGARForm 4 filed Jun 28, 2024